Literature DB >> 21555654

Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.

Tania Weber Furlanetto1, Gustavo Adolpho Moreira Faulhaber.   

Abstract

Severe magnesium deficiency associated with proton pump inhibitors (PPIs) has been described recently with clinical presentations varying from life-threatening conditions to muscle cramps and paresthesias. Probably milder cases go undetected. We report an asymptomatic case of hypomagnesemia associated with chronic use of PPIs in a 67-year-old woman. She had had symptoms of gastroesophageal reflux disease for several years, which abated partially with PPIs, and denied any other symptoms or medications. Her initial evaluation showed an unexplained hypomagnesemia with a very low magnesium excretion rate in urine. Serum calcium, phosphorus, potassium, and glucose levels and renal function were normal. After PPI withdrawal, serum and urinary magnesium levels normalized.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21555654     DOI: 10.1001/archinternmed.2011.199

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  20 in total

1.  Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy.

Authors:  Tiberiu Hershcovici; Ronnie Fass
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

2.  Proton pump inhibitor associated hypomagnasaemia - a cause for concern?

Authors:  Joe Begley; Trevor Smith; Kirsty Barnett; Paul Strike; Adnan Azim; Claire Spake; Tristan Richardson
Journal:  Br J Clin Pharmacol       Date:  2016-01-25       Impact factor: 4.335

3.  Acute neurological symptoms secondary to hypomagnesemia induced by proton pump inhibitors: a case series.

Authors:  Luca Pasina; Danilo Zanotta; Silvana Puricelli; Guido Bonoldi
Journal:  Eur J Clin Pharmacol       Date:  2016-02-13       Impact factor: 2.953

4.  Factors influencing magnesium infusions in hematopoietic cell transplants.

Authors:  Michael S Gin; Todd W Canada
Journal:  Support Care Cancer       Date:  2019-02-11       Impact factor: 3.603

5.  Seizure and tetany secondary to hypomagnesaemic hypoparathyroidism induced by a proton-pump inhibitor.

Authors:  Luca Pasina; Danilo Zanotta; Silvana Puricelli; Guido Bonoldi
Journal:  Eur J Clin Pharmacol       Date:  2016-11-28       Impact factor: 2.953

6.  Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?

Authors:  Alexander L Fohl; Randolph E Regal
Journal:  World J Gastrointest Pharmacol Ther       Date:  2011-06-06

7.  Evaluation of electrolyte repletion in hematopoietic cell transplant patients receiving H-2 receptor antagonists or proton pump inhibitors.

Authors:  K Smith; M L Gatesman; S E Harpe; W Clark
Journal:  Bone Marrow Transplant       Date:  2014-05-12       Impact factor: 5.483

8.  Proton-pump inhibitor use is associated with low serum magnesium concentrations.

Authors:  John Danziger; Jeffrey H William; Daniel J Scott; Joon Lee; Li-wei Lehman; Roger G Mark; Michael D Howell; Leo A Celi; Kenneth J Mukamal
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

9.  Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.

Authors:  Ioannis Koulouridis; Mansour Alfayez; Hocine Tighiouart; Nicolaos E Madias; David M Kent; Jessica K Paulus; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2013-05-10       Impact factor: 8.860

10.  Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6.

Authors:  A L L Lameris; M W Hess; I van Kruijsbergen; J G J Hoenderop; R J M Bindels
Journal:  Pflugers Arch       Date:  2013-06-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.